MIT induced cleavage of caspase 3, a process that was remarkably weakened by SPINK1 but can be maintained upon elimination of SPINK1 from stromal cells (Supplementary Fig. 4f), implying SPINK1 drives cancer resistance largely via a caspase-counteracting mechanism. Here, SPINK1 is linked to cancer.